Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Popov

Showing results (421-430 of 434) with videos related to

Pageof 44
Sort By:
Immunity|September 10, 2020
IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against StaphylococcusaureusPhilipp Starkl, Martin L Watzenboeck, Lauren M Popov, et al.
British Journal of Haematology|March 14, 2021
Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual diseaseEkaterina Mikhailova, Alexandra Semchenkova, Olga Illarionova, et al.
Terapevticheskii Arkhiv|February 1, 2019
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experienceY Y Dyakonova, O I Bydanov, A M Popov, et al.
Hematology (Amsterdam, Netherlands)|March 27, 2014
An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohortAlexandra A Sipol, Elena V Babenko, Vyacheslav I Borisov, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|May 11, 2005
[Evaluation of the immunogenic and reactogenic properties of vaccine "Euvax B" in persons aged 16-18 years in different geographical zones of Russia]S N Kuzin, A L Zaplatnikov, F A Ibragimova, et al.
The Journal of Rheumatology|August 17, 2014
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritisWalter P Maksymowych, Stanley J Naides, Vivian Bykerk, et al.
British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
The Lancet. Haematology|February 10, 2025
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trialJorge E Cortes, Dong-Wook Kim, Tapan Saikia, et al.
Science (New York, N.Y.)|July 17, 2025
Controlled colonization of the human gut with a genetically engineered microbial therapeuticWeston R Whitaker, Zachary N Russ, Elizabeth Stanley Shepherd, et al.
American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Pageof 44

Showing results (421-430 of 434) with videos related to

Sort By:
Pageof 44
Immunity|September 10, 2020
IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against StaphylococcusaureusPhilipp Starkl, Martin L Watzenboeck, Lauren M Popov, et al.
British Journal of Haematology|March 14, 2021
Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual diseaseEkaterina Mikhailova, Alexandra Semchenkova, Olga Illarionova, et al.
Terapevticheskii Arkhiv|February 1, 2019
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experienceY Y Dyakonova, O I Bydanov, A M Popov, et al.
Hematology (Amsterdam, Netherlands)|March 27, 2014
An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohortAlexandra A Sipol, Elena V Babenko, Vyacheslav I Borisov, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|May 11, 2005
[Evaluation of the immunogenic and reactogenic properties of vaccine "Euvax B" in persons aged 16-18 years in different geographical zones of Russia]S N Kuzin, A L Zaplatnikov, F A Ibragimova, et al.
The Journal of Rheumatology|August 17, 2014
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritisWalter P Maksymowych, Stanley J Naides, Vivian Bykerk, et al.
British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
The Lancet. Haematology|February 10, 2025
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trialJorge E Cortes, Dong-Wook Kim, Tapan Saikia, et al.
Science (New York, N.Y.)|July 17, 2025
Controlled colonization of the human gut with a genetically engineered microbial therapeuticWeston R Whitaker, Zachary N Russ, Elizabeth Stanley Shepherd, et al.
American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Pageof 44